IV 

115TH CONGRESS 

2D SESSION H. RES. 812 

Supporting quality of life for prostate cancer patients. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 10, 2018 

Mr. PAULSEN (for himself and Mr. PAYNE) submitted the following resolution; 

which was referred to the Committee on Energy and Commerce, and in 

addition to the Committees on Ways and Means, and Veterans’ Affairs, 

for a period to be subsequently determined by the Speaker, in each case 

for consideration of such provisions as fall within the jurisdiction of the 

committee concerned 

RESOLUTION 

Supporting quality of life for prostate cancer patients. 

Whereas an estimated 164,690 men will be diagnosed with 

prostate cancer in 2018 adding to the estimated more 

than 2,900,000 men currently living with prostate cancer 

in the United States; 

Whereas approximately 15 percent of men will be diagnosed 

with prostate cancer during their lifetime and prostate 

cancer is the second leading cause of death in men in the 

United States; 

Whereas African-American males suffer from a 60-percent 

higher incidence of prostate cancer than White males and 

have an almost 250-percent higher mortality rate than 

White males; 


lotter on DSKBCFDHB2PROD with BILLS
2 

•HRES 812 IH 

Whereas certain veterans populations may have nearly twice 

the incidence of prostate cancer as the general population 

of the United States; 

Whereas there are a number of options available to men to 

treat prostate cancer, including radiation, hormone therapy, chemotherapy, and a radical prostatectomy; 

Whereas many men who undertake these treatment options 

for their prostate cancer will experience significant side 

effects including incontinence and impotence; 

Whereas the side effects of prostate treatment can negatively 

affect a prostate cancer survivor’s quality of life and contribute to depression and anxiety; 

Whereas the spouse or partner of the prostate cancer survivor 

is emotionally impacted as the intimacy of the relationship can become strained; 

Whereas prostate cancer survivors suffering from the side effects of treatment deserve access to the prosthetic urologic interventions and reconstructive surgeries that can 

restore the patient to a physical state similar to that 

prior to the prostate cancer treatment; 

Whereas the need for these urologic restoration products can 

also be a last line of intervention for patients suffering 

from diabetes, cardiovascular disease, Parkinson’s disease, or multiple sclerosis; and 

Whereas Medicare and the Veterans’ Administration currently cover medical devices such as artificial urinary 

sphincters and penile prosthesis: Now, therefore, be it 

1 Resolved, That it is the sense of the House of Rep2 resentatives that Congress should protect Medicare or Vet3 erans’ Administration benefits for medical device treatVerDate Sep 11 2014 02:14 Apr 11, 2018 Jkt 079200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\HR812.IH HR812

lotter on DSKBCFDHB2PROD with BILLS
3 

•HRES 812 IH 

1 ments for male incontinence and impotence that result 

2 from treatment for prostate cancer, diabetes, cardio3 vascular disease, Parkinson’s disease, or multiple sclerosis 

4 and that any such coverage decisions should be based on 

5 data and made after careful review by medical experts 

6 with a critical eye toward the impact of coverage decisions 

7 on the Medicare and Veterans’ Administration popu8 lations. 

Æ 


lotter on DSKBCFDHB2PROD with BILLS